New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr

Updated on: March 01,2024

New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr

Updated on:March 01,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on: July 08,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on:July 08,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on: January 02,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on:January 02,2024

Alterations in the blood immune system found to increase cancer risk

by Germans Trias i Pujol Research InstitutePleiotropicRNYsare linked to SLE risk and plasmaRNYsare relatively abundant preceding breast cancer diagnosis.aScatter pl

Updated on: April 22,2024

Alterations in the blood immune system found to increase cancer risk

by Germans Trias i Pujol Research InstitutePleiotropicRNYsare linked to SLE risk and plasmaRNYsare relatively abundant preceding breast cancer diagnosis.aScatter pl

Updated on:April 22,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on: March 14,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on:March 14,2024

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Updated on: November 09,2024

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Updated on:November 09,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on: January 29,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on:January 29,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024

Study reveals root of triple negative breast cancer immunosuppression and chemoresistance

by Hokkaido UniversityIn IL-34-expressing tumors, blood vessels were observed only in the outer layer, whereas in IL-34-deficient tumors, blood vessels were observed in the whole area (modified f

Updated on: February 20,2024

Study reveals root of triple negative breast cancer immunosuppression and chemoresistance

by Hokkaido UniversityIn IL-34-expressing tumors, blood vessels were observed only in the outer layer, whereas in IL-34-deficient tumors, blood vessels were observed in the whole area (modified f

Updated on:February 20,2024

Study could help explain why certain brain tumors don't respond well to immunotherapy

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread

Updated on: February 18,2024

Study could help explain why certain brain tumors don't respond well to immunotherapy

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread

Updated on:February 18,2024

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec

Updated on: March 06,2024

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec

Updated on:March 06,2024

Team identifies protein key to cancer cells ability to spread

by University of GuelphProfessor Jim Uniacke in his specialized lab. Credit: Rob O'FlanaganUniversity of Guelph scientists have made a discovery that could reduce the spread of cancer by hind

Updated on: May 27,2024

Team identifies protein key to cancer cells ability to spread

by University of GuelphProfessor Jim Uniacke in his specialized lab. Credit: Rob O'FlanaganUniversity of Guelph scientists have made a discovery that could reduce the spread of cancer by hind

Updated on:May 27,2024